CD34 Human, Sf9

CD34 Human Recombinant, Sf9
Cat. No.
BT29023
Source
Sf9, Baculovirus cells.
Synonyms
CD34 molecule, Hematopoietic progenitor cell antigen CD34, CD34 Antigen, CD34.
Appearance
Sterile filtered colorless solution.
Purity
Greater than 95.0% as determined by SDS-PAGE.
Usage
Prospec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

CD34 Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 268 amino acids (32-290a.a.) and having a molecular mass of 28.6kDa (Molecular size on SDS-PAGE will appear at approximately 40-57kDa).
CD34 is fused with a 6 amino acids His tag at C-Terminus and purified by proprietary chromatographic techniques.

Product Specs

Introduction
CD34 is a transmembrane glycoprotein found on the surface of certain cells, including early blood-forming cells. It is a marker used to identify and study these cells. CD34 has also been linked to the formation of new blood vessels, a process important in tumor growth and potential relapse.
Description
This product consists of the human CD34 protein, which has been produced in insect cells. It is a single chain protein with sugar modifications and a size of approximately 28.6 kDa. To aid in purification and detection, a small tag of 6 histidine amino acids is added at the end of the protein. The purified protein is supplied in a solution buffer.
Physical Appearance
A clear and colorless liquid that has been sterilized by filtration.
Formulation
The CD34 protein is provided at a concentration of 0.25 mg/ml in a solution containing phosphate buffered saline at pH 7.4 and 10% glycerol.
Stability
For short-term storage of 2-4 weeks, keep at 4°C. For longer storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for extended storage. Avoid repeated freezing and thawing.
Purity
The purity of the protein is greater than 95% as assessed by SDS-PAGE analysis.
Synonyms
CD34 molecule, Hematopoietic progenitor cell antigen CD34, CD34 Antigen, CD34.
Source
Sf9, Baculovirus cells.
Amino Acid Sequence
ADLSLDNNGT ATPELPTQGT FSNVSTNVSY QETTTPSTLG STSLHPVSQH GNEATTNITE TTVKFTSTSV ITSVYGNTNS SVQSQTSVIS TVFTTPANVS TPETTLKPSL SPGNVSDLST TSTSLATSPT KPYTSSSPIL SDIKAEIKCS GIREVKLTQG ICLEQNKTSS CAEFKKDRGE GLARVLCGEE QADADAGAQV CSLLLAQSEV RPQCLLLVLA NRTEISSKLQ LMKKHQSDLK KLGILDFTEQ DVASHQSYSQ KTHHHHHH.

Product Science Overview

Structure and Function

CD34 is a transmembrane phosphoglycoprotein that is heavily glycosylated. It is expressed on the surface of early hematopoietic and vascular-associated tissue. The protein is involved in cell adhesion, which is essential for the migration of HSPCs to the bone marrow. CD34 acts as a ligand for selectins, which are cell adhesion molecules that mediate the interaction between leukocytes and endothelial cells .

Role in Hematopoiesis

Hematopoiesis is the process by which all blood cells are produced from hematopoietic stem cells. CD34 is a critical marker used to enrich donor bone marrow with HSPCs before bone marrow transplantation. It is also used to identify and isolate HSPCs for research and clinical applications. CD34-positive HSPCs exhibit E-selectin binding activity, which is essential for their migration and homing to the bone marrow .

Recombinant CD34 (Human, Sf9)

Recombinant CD34 (Human, Sf9) refers to the CD34 protein that has been produced using the Sf9 insect cell expression system. This system is commonly used for the production of recombinant proteins because it allows for proper protein folding and post-translational modifications, which are essential for the protein’s biological activity. The recombinant CD34 produced in Sf9 cells retains its functional properties and can be used in various research and clinical applications .

Clinical Applications

CD34-positive cells are widely used in clinical settings, particularly in bone marrow transplantation. The ability to isolate and enrich HSPCs using CD34 as a marker has significantly improved the outcomes of bone marrow transplants. Additionally, CD34-positive cells are being explored for their potential in regenerative medicine, including the treatment of myocardial infarction and other degenerative diseases .

Research Applications

In research, CD34 is used to study the biology of hematopoietic stem cells and their role in blood cell formation. It is also used to investigate the mechanisms of cell adhesion and migration, as well as the interactions between HSPCs and the bone marrow microenvironment. The recombinant CD34 protein produced in Sf9 cells provides a valuable tool for these studies, allowing researchers to explore the protein’s structure and function in detail .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.